• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药使上皮细胞对毒素介导的线粒体损伤敏感。

Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to toxin-mediated mitochondrial damage.

机构信息

Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Sci Adv. 2023 Jul 21;9(29):eadh5552. doi: 10.1126/sciadv.adh5552. Epub 2023 Jul 19.

DOI:10.1126/sciadv.adh5552
PMID:37467340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10355836/
Abstract

damages the colonic mucosa through the action of two potent exotoxins. Factors shaping pathogenesis are incompletely understood but are likely due to the ecological factors in the gastrointestinal ecosystem, mucosal immune responses, and environmental factors. Little is known about the role of pharmaceutical drugs during infection (CDI), but recent studies have demonstrated that nonsteroidal anti-inflammatory drugs (NSAIDs) worsen CDI. The mechanism underlying this phenomenon remains unclear. Here, we show that NSAIDs exacerbate CDI by disrupting colonic epithelial cells (CECs) and sensitizing cells to toxin-mediated damage independent of their canonical role of inhibiting cyclooxygenase (COX) enzymes. Notably, we find that NSAIDs and toxins target the mitochondria of CECs and enhance toxin-mediated damage. Our results demonstrate that NSAIDs exacerbate CDI by synergizing with toxins to damage host cell mitochondria. Together, this work highlights a role for NSAIDs in exacerbating microbial infection in the colon.

摘要

通过两种强效外毒素的作用,破坏结肠黏膜。发病机制的影响因素尚不完全清楚,但可能与胃肠道生态系统中的生态因素、黏膜免疫反应和环境因素有关。在感染(CDI)期间,药物的作用知之甚少,但最近的研究表明,非甾体抗炎药(NSAIDs)会使 CDI 恶化。这种现象的机制尚不清楚。在这里,我们表明 NSAIDs 通过破坏结肠上皮细胞(CEC)并使细胞对毒素介导的损伤敏感,从而加重 CDI,而与它们抑制环氧化酶(COX)酶的典型作用无关。值得注意的是,我们发现 NSAIDs 和毒素靶向 CEC 的线粒体,并增强毒素介导的损伤。我们的结果表明,NSAIDs 通过与毒素协同作用破坏宿主细胞的线粒体来加重 CDI。总的来说,这项工作强调了 NSAIDs 在加重结肠中微生物感染中的作用。

相似文献

1
Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to toxin-mediated mitochondrial damage.非甾体抗炎药使上皮细胞对毒素介导的线粒体损伤敏感。
Sci Adv. 2023 Jul 21;9(29):eadh5552. doi: 10.1126/sciadv.adh5552. Epub 2023 Jul 19.
2
Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Colitis while Dysregulating the Inflammatory Response.非甾体抗炎药改变微生物群并加重结肠炎,同时使炎症反应失调。
mBio. 2019 Jan 8;10(1):e02282-18. doi: 10.1128/mBio.02282-18.
3
Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection.止痛药:非甾体抗炎药与艰难梭菌感染之间的相互作用
Curr Opin Microbiol. 2022 Feb;65:167-174. doi: 10.1016/j.mib.2021.11.011. Epub 2021 Dec 8.
4
The microbial metabolite urolithin A reduces toxin expression and toxin-induced epithelial damage.微生物代谢产物尿石素A可降低毒素表达及毒素诱导的上皮损伤。
mSystems. 2024 Feb 20;9(2):e0125523. doi: 10.1128/msystems.01255-23. Epub 2024 Jan 9.
5
Plakoglobin and High-Mobility Group Box 1 Mediate Intestinal Epithelial Cell Apoptosis Induced by Clostridioides difficile TcdB.桥粒芯糖蛋白和高迁移率族蛋白 1 介导艰难梭菌 TcdB 诱导的肠道上皮细胞凋亡。
mBio. 2022 Oct 26;13(5):e0184922. doi: 10.1128/mbio.01849-22. Epub 2022 Aug 31.
6
S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Infection by Modulating Inflammatory Response.S100B 抑制通过调节炎症反应减轻 感染期间的肠道损伤和腹泻严重程度。
Front Cell Infect Microbiol. 2021 Sep 10;11:739874. doi: 10.3389/fcimb.2021.739874. eCollection 2021.
7
Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.经直肠滴注艰难梭菌毒素 A 可引发结肠炎症和组织损伤:艰难梭菌毒素暴露的新型且高效的小鼠模型的建立。
Infect Immun. 2012 Dec;80(12):4474-84. doi: 10.1128/IAI.00933-12. Epub 2012 Oct 8.
8
Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.非产毒艰难梭菌 CCUG37785 株的基因组和表型特征及其预防艰难梭菌感染的治疗潜力的研究
Microbiol Spectr. 2022 Apr 27;10(2):e0178821. doi: 10.1128/spectrum.01788-21. Epub 2022 Mar 22.
9
Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.人源单克隆抗体针对艰难梭菌毒素 A 和 B 可抑制毒素在人结肠和外周血单核细胞中的炎症和组织学反应。
Antimicrob Agents Chemother. 2013 Jul;57(7):3214-23. doi: 10.1128/AAC.02633-12. Epub 2013 Apr 29.
10
Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.非达霉素可抑制艰难梭菌毒素A介导的小鼠回肠炎。
Antimicrob Agents Chemother. 2014 Aug;58(8):4642-50. doi: 10.1128/AAC.02783-14. Epub 2014 Jun 2.

引用本文的文献

1
Dietary Fiber Modulates the Window of Susceptibility to Clostridioides difficile Infection.膳食纤维调节艰难梭菌感染的易感性窗口期。
Gastroenterology. 2025 May 16. doi: 10.1053/j.gastro.2025.04.027.
2
Gene Expression Dysregulation in Whole Blood of Patients with Infection.感染患者全血中的基因表达失调
Int J Mol Sci. 2024 Nov 25;25(23):12653. doi: 10.3390/ijms252312653.
3
A multivalent mRNA-LNP vaccine protects against infection.一种多价 mRNA-LNP 疫苗可预防 感染。

本文引用的文献

1
Enterococci enhance Clostridioides difficile pathogenesis.肠球菌增强艰难梭菌的发病机制。
Nature. 2022 Nov;611(7937):780-786. doi: 10.1038/s41586-022-05438-x. Epub 2022 Nov 16.
2
Dietary fat promotes antibiotic-induced Clostridioides difficile mortality in mice.饮食中的脂肪会促进小鼠对抗生素诱导的艰难梭菌死亡。
NPJ Biofilms Microbiomes. 2022 Apr 1;8(1):15. doi: 10.1038/s41522-022-00276-1.
3
Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection.止痛药:非甾体抗炎药与艰难梭菌感染之间的相互作用
Science. 2024 Oct 4;386(6717):69-75. doi: 10.1126/science.adn4955. Epub 2024 Oct 3.
4
Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies.评估非甾体抗炎药在2019冠状病毒病中的作用:免疫调节机制与未来治疗策略
Heliyon. 2024 Feb 2;10(3):e25734. doi: 10.1016/j.heliyon.2024.e25734. eCollection 2024 Feb 15.
Curr Opin Microbiol. 2022 Feb;65:167-174. doi: 10.1016/j.mib.2021.11.011. Epub 2021 Dec 8.
4
Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.质子泵抑制剂的使用与社区获得性艰难梭菌感染的风险。
Clin Infect Dis. 2021 Jun 15;72(12):e1084-e1089. doi: 10.1093/cid/ciaa1857.
5
Using flow cytometry for mitochondrial assays.使用流式细胞术进行线粒体分析。
MethodsX. 2020 May 28;7:100938. doi: 10.1016/j.mex.2020.100938. eCollection 2020.
6
ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity.ZupT 促进艰难梭菌对宿主介导的营养免疫的耐药性。
mSphere. 2020 Mar 11;5(2):e00061-20. doi: 10.1128/mSphere.00061-20.
7
A High-Fat/High-Protein, Atkins-Type Diet Exacerbates () Infection in Mice, whereas a High-Carbohydrate Diet Protects.高脂/高蛋白、阿特金斯式饮食会加剧小鼠的()感染,而高碳水化合物饮食则具有保护作用。 (注:原文括号处内容缺失)
mSystems. 2020 Feb 11;5(1):e00765-19. doi: 10.1128/mSystems.00765-19.
8
Nonsteroidal Anti-Inflammatory Drugs Impact on the Outcomes of Hospitalized Patients with Infection.非甾体抗炎药对住院感染患者预后的影响
Clin Exp Gastroenterol. 2019 Dec 10;12:449-456. doi: 10.2147/CEG.S223886. eCollection 2019.
9
Misoprostol protects mice against severe Clostridium difficile infection and promotes recovery of the gut microbiota after antibiotic perturbation.米索前列醇可保护小鼠免受严重艰难梭菌感染,并促进抗生素扰乱后肠道微生物群的恢复。
Anaerobe. 2019 Aug;58:89-94. doi: 10.1016/j.anaerobe.2019.06.006. Epub 2019 Jun 17.
10
Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Colitis while Dysregulating the Inflammatory Response.非甾体抗炎药改变微生物群并加重结肠炎,同时使炎症反应失调。
mBio. 2019 Jan 8;10(1):e02282-18. doi: 10.1128/mBio.02282-18.